Then, our current in vitro and in vivo study aimed to investigate the effect of lnc-KASRT on regulating malignant tumor behaviors and the implication of its interaction with KLF6 alternative splicing in osteosarcoma. This evidence concerns the gene KLF6 and osteosarcoma.